Credit rating agency Acuite has assigned ratings to Zim Laboratories’ Rs 125.50 crore bank facilities. The agency has assigned long-term rating of ‘BBB-’ and a Short Term rating of ‘A3’. Outlook for the long-term rating remained negative.
Zim Laboratories has established itself as one of the preferred healthcare solution providers in the field of New Drug Delivery Systems (NDDS).